Cargando…
A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB‐DH1 trial
Digital therapeutics is a new approach to treat hypertension via using software programs such as smartphone apps and/or device algorithms. We develop a HERB system—new interactive smartphone app (HERB Mobile) with web‐based patient management console (HERB Console)—to lower blood pressure (BP) based...
Autores principales: | Kario, Kazuomi, Nomura, Akihiro, Harada, Noriko, Tanigawa, Tomoyuki, So, Ryuhei, Nakagawa, Kiyose, Suzuki, Shin, Okura, Ayako, Hida, Eisuke, Satake, Kohta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589405/ https://www.ncbi.nlm.nih.gov/pubmed/32815648 http://dx.doi.org/10.1111/jch.13993 |
Ejemplares similares
-
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
por: Kario, Kazuomi, et al.
Publicado: (2021) -
Digital therapeutics for essential hypertension using a smartphone application: A randomized, open‐label, multicenter pilot study
por: Kario, Kazuomi, et al.
Publicado: (2021) -
Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial
por: Tanigawa, Tomoyuki, et al.
Publicado: (2019) -
The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
por: Kario, Kazuomi, et al.
Publicado: (2022) -
Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial
por: Nomura, Akihiro, et al.
Publicado: (2019)